Cytogenetic and molecular characterization of plutonium-induced rat osteosarcomas.
The association between ionizing radiation and the subsequent development of osteosarcoma has been well described, but little is known about the cytogenetic and molecular events, which could be involved in the formation of radiation-induced osteosarcomas. Here, we performed comparative genomic hybridization (CGH) to detect chromosomal copy number changes in a series of 16 rat osteosarcomas induced by injection of plutonium-238. Recurrent gains/amplifications were observed at chromosomal regions 3p12-q12, 3q41-qter, 4q41-qter, 6q12-q16, 7q22-q34, 8q11-q23, 9q11-q22, 10q32.1-qter, and 12q, whereas recurrent losses were observed at 1p, 1q, 3q23-q35, 5q21-q33, 8q24-q31, 10q22-q25, 15p, 15q, and 18q. The gained region at 7q22-q34 was homologous to human chromosome bands 12q13-q15/8q24/22q11-q13, including the loci of Mdm2, Cdk4, c-Myc and Pdgf-b genes. The lost regions at 5q21-q33, 10q22-q25 and 15q contained tumor suppressor genes such as p16INK4a/p19ARF, Tp53 and Rb1. To identify potential target gene(s) for the chromosomal aberrations, we compared the expression levels of several candidate genes, located within the regions of frequent chromosomal aberrations, between the tumors and normal osteoblasts by using quantitative RT-PCR analysis. The Cdk4, c-Myc, Pdgf-b and p57KIP2 genes were thought to be possible target genes for the frequent chromosomal gain at 7q22-34 and loss at 1q in the tumors, respectively. In addition, mutations of the Tp53 gene were found in 27% (4 of 15) osteosarcomas. Our data may contribute to further understanding of the molecular mechanisms underlying osteosarcomas induced by ionizing radiation in human.
Roch-Lefevre
Sandrine
S
LCE/iRCM/DSV/CEA, route du Panorama, BP 6, 92265 Fontenay-aux-Roses cedex, France.
Daino
Kazuhiro
K
Altmeyer-Morel
Sandrine
S
Guilly
Marie-Noëlle
MN
Chevillard
Sylvie
S
D000818:Animals; D002869:Chromosome Aberrations; D055028:Comparative Genomic Hybridization; D003582:Cytogenetics; D004252:DNA Mutational Analysis; D005260:Female; D018628:Gene Dosage; D008297:Male; D009381:Neoplasms, Radiation-Induced / Q000235:genetics*; D012516:Osteosarcoma / Q000209:etiology* / Q000235:genetics*; D011005:Plutonium / Q000633:toxicity*; D011839:Radiation, Ionizing; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction
D011005:Plutonium